Insider Transactions in Q2 2024 at Intra Cellular Therapies, Inc. (ITCI)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2024
|
Rory B Riggs |
BUY
Grant, award, or other acquisition
|
Direct |
262
+0.22%
|
$17,816
$68.49 P/Share
|
|
Jun 28
2024
|
Robert L Van Nostrand |
BUY
Grant, award, or other acquisition
|
Direct |
83
+0.73%
|
$5,644
$68.49 P/Share
|
|
Jun 24
2024
|
Rory B Riggs |
SELL
Open market or private sale
|
Direct |
4,462
-3.69%
|
$334,650
$75.57 P/Share
|
|
Jun 24
2024
|
Rory B Riggs |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+14.18%
|
$320,000
$16.86 P/Share
|
|
Jun 23
2024
|
Rory B Riggs |
BUY
Exercise of conversion of derivative security
|
Direct |
1,567
+1.53%
|
-
|
|
Jun 23
2024
|
Joel S Marcus |
BUY
Exercise of conversion of derivative security
|
Direct |
1,567
+3.66%
|
-
|
|
Jun 23
2024
|
Eduardo Rene Salas |
BUY
Exercise of conversion of derivative security
|
Direct |
1,567
+50.0%
|
-
|
|
Jun 23
2024
|
Robert L Van Nostrand |
BUY
Exercise of conversion of derivative security
|
Direct |
1,567
+12.22%
|
-
|
|
Jun 18
2024
|
Robert L Van Nostrand |
SELL
Open market or private sale
|
Direct |
20,000
-41.68%
|
$1,500,000
$75.89 P/Share
|
|
Jun 18
2024
|
Robert L Van Nostrand |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+40.25%
|
$320,000
$16.86 P/Share
|
|
Apr 24
2024
|
Sharon Mates Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,020
+0.93%
|
$340,340
$17.22 P/Share
|